Short Interest in Sysmex Co. (OTCMKTS:SSMXY) Decreases By 25.0%

Sysmex Co. (OTCMKTS:SSMXY) was the target of a large decrease in short interest during the month of February. As of February 28th, there was short interest totalling 3,000 shares, a decrease of 25.0% from the February 13th total of 4,000 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average daily volume of 112,900 shares, the short-interest ratio is presently 0.0 days.

Sysmex Stock Performance

OTCMKTS:SSMXY opened at $19.32 on Friday. The company has a quick ratio of 2.42, a current ratio of 3.19 and a debt-to-equity ratio of 0.11. The firm’s fifty day simple moving average is $18.47 and its 200 day simple moving average is $19.10. Sysmex has a twelve month low of $14.38 and a twelve month high of $28.41. The stock has a market cap of $12.16 billion, a P/E ratio of 35.86 and a beta of 0.88.

Sysmex (OTCMKTS:SSMXY) last announced its quarterly earnings data on Wednesday, February 12th. The company reported $0.17 EPS for the quarter. As a group, research analysts predict that Sysmex will post 0.57 EPS for the current year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.